2.62
1.16%
0.03
908 Devices Inc stock is traded at $2.62, with a volume of 135.09K.
It is up +1.16% in the last 24 hours and down -20.36% over the past month.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
See More
Previous Close:
$2.59
Open:
$2.57
24h Volume:
135.09K
Relative Volume:
0.58
Market Cap:
$90.89M
Revenue:
$50.23M
Net Income/Loss:
$-36.40M
P/E Ratio:
-2.2017
EPS:
-1.19
Net Cash Flow:
$-27.10M
1W Performance:
+2.34%
1M Performance:
-20.36%
6M Performance:
-59.57%
1Y Performance:
-61.75%
908 Devices Inc Stock (MASS) Company Profile
Name
908 Devices Inc
Sector
Industry
Phone
978-729-4478
Address
645 SUMMER STREET, BOSTON
Compare MASS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
MASS
908 Devices Inc
|
2.62 | 90.89M | 50.23M | -36.40M | -27.10M | -1.19 |
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
908 Devices Inc Stock (MASS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-13-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
Feb-07-23 | Initiated | Stephens | Overweight |
Oct-15-21 | Resumed | Cowen | Outperform |
Jan-12-21 | Initiated | Cowen | Outperform |
Jan-12-21 | Initiated | SVB Leerink | Outperform |
Jan-12-21 | Initiated | Stifel | Buy |
Jan-12-21 | Initiated | William Blair | Outperform |
View All
908 Devices Inc Stock (MASS) Latest News
Earnings Update: 908 Devices Inc. (NASDAQ:MASS) Just Reported And Analysts Are Trimming Their Forecasts - Simply Wall St
Analysts Have Lowered Expectations For 908 Devices Inc. (NASDAQ:MASS) After Its Latest Results - Yahoo Finance
FY2024 EPS Estimates for 908 Devices Cut by Leerink Partnrs - MarketBeat
Granahan Investment Management Reduces Stake in 908 Devices Inc - GuruFocus.com
Leerink Partners Reaffirms “Market Perform” Rating for 908 Devices (NASDAQ:MASS) - Defense World
Leerink Partnrs Downgrades 908 Devices (NASDAQ:MASS) to Hold - Defense World
FY2024 EPS Estimates for 908 Devices Lifted by William Blair - MarketBeat
908 Devices Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Boston firm to shift manufacturing to North Carolina - The Business Journals
908 Devices downgraded to Market Perform from Outperform at Leerink - TipRanks
Earnings call: 908 Devices adjusts revenue guidance amid market challenges - Investing.com
Leerink downgrades 908 Devices stock rating on market headwinds, slashes PT - Investing.com
908 Devices Inc. (NASDAQ:MASS) Q3 2024 Earnings Call Transcript - Insider Monkey
Leerink Partners Reaffirms Market Perform Rating for 908 Devices (NASDAQ:MASS) - MarketBeat
908 Devices price target lowered to $6 from $17 at Stifel - TipRanks
908 Devices Inc (MASS) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges - GuruFocus.com
908 Devices Inc (MASS) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges By GuruFocus - Investing.com Canada
908 Devices Inc. Reports Q3 2024 Financial Results - TipRanks
908 Devices stock hits 52-week low at $3.12 amidst market challenges - Investing.com Canada
908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook - BioSpace
908 Devices Inc. (MASS) Reports Q3 Loss, Lags Revenue Estimates - MSN
908 Devices Restructures for Cost Efficiency and Growth - TipRanks
908 Devices Inc. (MASS) Quarterly 10-Q Report - Quartz
908 Devices Inc. Intends to Transition All Manufacturing Operations Currently Undertaken in Boston, Massachusetts to Its Facilities in Morrisville, North Carolina and Danbury, Connecticut - Marketscreener.com
What To Expect From 908 Devices Inc (MASS) Q3 2024 Earnings - GuruFocus.com
908 Devices (MASS) Set to Announce Quarterly Earnings on Tuesday - Defense World
ARK Investment Management LLC Sells 718,082 Shares of 908 Devices Inc. (NASDAQ:MASS) - MarketBeat
US Penny Stocks: 908 Devices Leads This Trio - Simply Wall St
Recent uptick might appease 908 Devices Inc. (NASDAQ:MASS) institutional owners after losing 41% over the past year - Simply Wall St
908 Devices (MASS) Scheduled to Post Earnings on Tuesday - MarketBeat
908 Devices to Participate in Upcoming Investor Conferences - BioSpace
908 Devices stock hits 52-week low at $3.24 amid market challenges - Investing.com Australia
908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024 - Business Wire
Investor presentation (10/21/2024 04: 00 - Marketscreener.com
908 Devices (NASDAQ:MASS) PT Lowered to $12.00 at Leerink Partners - Defense World
Leerink Partners Lowers 908 Devices (NASDAQ:MASS) Price Target to $12.00 - MarketBeat
Millennium Management LLC Increases Stock Holdings in 908 Devices Inc. (NASDAQ:MASS) - MarketBeat
908 Devices stock hits 52-week low at $3.35 amid market challenges - Investing.com
908 Devices Inc (MASS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges - Yahoo Finance
HazSim Enters South American Market with New Partner - Firehouse
908 Devices Inc. (NASDAQ:MASS) Shares Acquired by American Century Companies Inc. - Defense World
908 Devices Inc Stock (MASS) Financials Data
Revenue
Net Income
Cash Flow
EPS
908 Devices Inc Stock (MASS) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Eisenberg Marcia | Director |
Jun 07 '24 |
Option Exercise |
0.00 |
682 |
0 |
6,816 |
Knopp Kevin J. | President and CEO |
May 13 '24 |
Buy |
6.42 |
10,000 |
64,200 |
508,981 |
Knopp Kevin J. | President and CEO |
May 10 '24 |
Buy |
5.77 |
10,000 |
57,700 |
498,981 |
Knopp Kevin J. | President and CEO |
May 09 '24 |
Buy |
5.83 |
10,000 |
58,300 |
488,981 |
Knopp Kevin J. | President and CEO |
May 08 '24 |
Buy |
5.72 |
10,000 |
57,200 |
478,981 |
Knopp Kevin J. | President and CEO |
May 07 '24 |
Buy |
5.60 |
10,000 |
56,000 |
468,981 |
Knopp Kevin J. | President and CEO |
Apr 16 '24 |
Option Exercise |
1.75 |
47,000 |
82,250 |
458,981 |
Brown Christopher D. | Chief Product Officer |
Apr 01 '24 |
Option Exercise |
1.75 |
3,600 |
6,300 |
884,994 |
Griffith Joseph H. IV | Chief Financial Officer |
Mar 26 '24 |
Option Exercise |
1.58 |
8,437 |
13,330 |
93,437 |
Griffith Joseph H. IV | Chief Financial Officer |
Feb 02 '24 |
Sale |
7.09 |
9,711 |
68,873 |
80,000 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):